


































































Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community for help and clear up your study doubts
Discover the best universities in your country according to Docsity users
Free resources
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
An overview of Dengue Fever and Dengue Hemorrhagic Fever, including their definitions, symptoms, and illness course. It also discusses the importance of patient monitoring and management, as well as the warning signs of severe dengue. The document emphasizes the need for differential diagnosis and clear definitions of warning signs and severity to avoid unnecessary hospitalization during an outbreak. useful for medical students and professionals studying infectious diseases and public health.
Typology: Essays (university)
1 / 74
This page cannot be seen from the preview
Don't miss anything!
3.1. Dengue Fever
3.1.1. Definition
Dengue fever is the most common fever in the age group of children, adolescents
and adults. In general, dengue fever is an acute febrile condition, which sometimes has a
biphasic pattern and is accompanied by severe headaches, myalgias, arthralgias, skin
rashes, leukopenia and thrombocytopenia. Even though dengue fever is actually a harmless
condition, it can cause sufferers to be unable to do activities due to severe headaches,
muscle, joint and bone pain (break-bone fever), especially in adults. Sometimes atypical
bleeding occurs, such as gastrointestinal bleeding, hypermenorrhea, and massive epistaxis.
In areas experiencing dengue fever epidemics, transmission of dengue fever rarely occurs
between local residents
Dengue hemorrhagic fever (DHF) is more common in children under 15 years of
age in hyperendemic areas, and it is associated with recurrent dengue infection. However,
its incidence in adults is also increasing. DHF is characterized by a high fever with an
acute onset with symptoms and signs similar to the symptoms and signs of dengue fever in
the initial phase. In DHF, abnormalities in bleeding can be found, for example, a positive
tourniquet (rumple leed) test, petechiae, bruises and gastrointestinal bleeding in more
severe cases.
At the end of the febrile phase, there is a threat of hypovolemic shock (dengue
shock syndrome) due to plasma leakage. The emergence of warning signs such as
persistent vomiting, abdominal pain, lethargy, restlessness, irritability, and oliguria is an
important thing to be followed up immediately in order to prevent shock. Hemostatic
disorders and plasma leakage are the main pathophysiological processes in DHF.
Thrombocytopenia and increased hematocrit/hemoconcentration are features that are
invariably encountered before a reduction in fever/onset of shock. DHF mostly occurs in
children who get a second infection with the dengue virus. There are also reports of DHF
cases occurring in the first infections with DENV-1 and DENV-3 viruses as well as
infections in infants. 6
Most infections in the United States are brought in from other countries. Risk
factors for dengue include having antibodies to the dengue virus from a previous infection
(Vyas, et al, 2014). Dengue virus belongs to the genus Flavirus, family flaviridae, there are
4 serotypes of the virus with DEN-1, DEN-2, DEN-3 and DEN-4, all four of which are
found in Indonesia with the most den-3 serotypes. Infection with one serotype will produce
antibodies against the serotype in question, while the antibodies formed against the other
serotypes are very lacking, so they cannot provide adequate protection against other
serotypes. A person living in the epidermal area of dengue can be infected by 3 or 4
serotypes during his life. The four serotypes of dengue virus can be found in various
regions in Indonesia.
3.1.3. Symptom
Clinical features Dengue fever After an incubation period of an average of 4-
days (range, 3-16 days), various non-specific constitutional symptoms as well as
headache, back pain and malaise begin to appear. The uniqueness of the onset of dengue
fever is fever that rises suddenly with a sharp increase in temperature and is often
accompanied by facial flushing and headache. Occasionally, chills accompany a sudden
rise in temperature. After that, retro-orbital pain can appear which is especially felt when
moving the eyeball or if pressure is applied to the eyeball, photophobia, back pain,
muscle pain and bone/joint pain. Other symptoms that often appear are anorexia and
changes in tongue taste sensation, constipation, colicky abdominal pain. groin area pain,
sore throat and depression. These symptoms usually persist for several days to several
weeks. It is important to note that the symptoms of dengue fever vary widely in terms of
frequency and severity
Fever: body temperature usually ranges from 39 oC - 40 oC, fever has a biphasic
pattern, and lasts 5-7 days in most cases.
Skin rash: a diffuse rash of short duration appearing on the face, neck and chest in
the first 2 to 3 days; later, a marked rash appears as maculopapular or rubelliform lesions
on the 3rd and 4th day. At the end of the feverish period, or as soon as the temperature
begins to drop, the diffuse rash will disappear, and clusters of localized petechiae will
appear in such locations as the soles of the feet, feet, palms and arms. This healing rash has
the characteristic, namely, scattered petechiae between the surrounding areas of pale, and
normal surrounding skin. 11. Itchiness in the rash can be found
Bleeding manifestations: skin bleeding may be seen as a positive tourniquet test
and/or petechiae. Other bleeding such as massive epistaxis, hypermenorrhea and
gastrointestinal bleeding rarely occur in DD which is exacerbated by thrombocytopenia.
Disease course: the duration and severity of DD varies between individuals in each
epidemic area. The recovery phase may be reached in a short time and without serious
problems but sometimes it is also often ongoing. In adults, it sometimes lasts for several
weeks and may be accompanied by asthenia and depression. Bradycardia often occurs
during the healing phase. Bleeding due to complications of DF, such as epistaxis, bleeding
gums, gastrointestinal bleeding, hematuria and hypermenorrhoea, is rare. However, heavy
bleeding (DD with unusual bleeding) is an important cause of death in DF. Dengue fever
with bleeding manifestations must be differentiated from dengue hemorrhagic fever
3.1.4. Illness Course
A. Dengue infection course
Dengue is an infection with complex manifestations with an incubation period of
4 to 10 days, and has 3 phases in the course of the disease, namely the febrile phase,
the critical phase, and the recovery phase (Figure 2). Accuracy and speed of
management as well as patient monitoring since the febrile phase, can reduce the risk
of death in severe dengue patients to <0.5%
: D e g r e e s C e l s i u s ( ° C )
The febrile phase is characterized by sudden
onset of high fever (can reach 40oC), continuous,
sometimes biphasic, and lasts 2–7 days. Fever is
accompanied by other common symptoms such as
facial flushing, headache, retroorbital pain, anorexia,
myalgia, and arthralgia. Other symptoms that may be
encountered are heartburn, nausea, vomiting, pain in
the right subcostal area or diffuse abdominal pain,
sometimes accompanied by sore throat. Redness of
the pharynx and conjunctiva (pharyngeal injection
and ciliary injection) may be found on physical
examination. In the early febrile phase, it is difficult
to distinguish clinically dengue from other non-
dengue febrile illnesses. A differential diagnosis is
deemed necessary so that appropriate management
can be carried out.
Table 1. Differential Diagnosis of Dengue in the Fever Phase
Dengue-like condition in the Fever Phase
Flue like syndrome Colds, influenza, measles, chikungunya, infections
mononucleosis, COVID-19, HIV seroconversion
Fever and rash Rubella, measles, fever scarlatina,
infection
meningococci, chikungunya, drug reactions
Diarrhea Rotavirus, another intestinal infection
Disease with
neurological manifestations
Meningoencephalitis, febrile seizures
Source: WHO. Dengue guidelines for diagnosis, treatment
and control, 2009.
Mild bleeding manifestations such as
petechiae and bleeding of the mucous membranes (eg
epistaxis and bleeding gums) may occur. Changes in
the results of a complete peripheral blood count
during the febrile phase in the form of a progressive
decrease in the number of leukocytes (leukopenia)
can guide clinicians to diagnose dengue. In dengue
infection the total number of leukocytes, neutrophils
and platelets is lower when compared to patients with
fever caused by other viruses in dengue endemic
areas.
The critical phase occurs when the fever
drops (time of fever defervescence), that is, when the
body temperature drops to 37.5–38o C or less and
remains below that temperature. This is when plasma
leakage occurs so that the patient can experience
hypovolemic shock. This symptom marks the
beginning of the critical phase. Danger signs
generally occur towards the end of the febrile phase,
form of increased capillary permeability together with an
increase in hematocrit levels. Warning signs are signs of
worsening dengue that need to be watched out for
Every time you find a patient with fever with
suspicion of dengue, it is necessary to do a serial
examination of the peripheral blood. The presence of
progressive leukopenia followed by a rapid decrease in the
number of platelets generally precedes plasma leakage. The
presence of severe plasma leakage (pleural effusion, ascites,
hemoconcentration, hypoalbumin and hypoproteinemia) is a
risk for shock. The patient's clinical condition worsened as
indicated by the presence of warning signs, referred to as
dengue with warning signs (Table 3).
Most cases of dengue with warning signs will
improve with early intravenous fluids, although some may
develop severe dengue.
Setting clear definitions for warning signs and the severity
of dengue infection is important to avoid unnecessary
hospitalization, especially during an outbreak.
Table 3. Warning signs
Parameter Description Explanation
Clinical Throw up Keep going-continuously
(persistent)
≥3 episodes of vomiting within 12 hours
and no
can tolerate oral fluids
Pain or tenderness
Abdomen
Abdominal pain is continuous and intensity
increased to interfere with activity
Restless/lethargic decreased consciousness and/or irritability
Mucosal bleeding 1) nosebleed/epistaxis
gum bleeding
petechial skin bleeding
purpura
5)bleeding in the conjunctiva,
subconjunctiva
Hepatomegaly >2cm An enlarged liver is palpable on
examination
physical > 2cm
Clinical found
fluid accumulation
palpebral edema, pleural effusion, ascites
Laboratory Hematocrit level and platelet count Enhancement hematocrit
comparedearlier,
accompanied by a rapid decline in
numbers
thrombocyte.
Source: Morra ME, et al. Definitions for warning signs and
signs of severe dengue according to the WHO 2009
classification: Systematic review of literature. Rev Med
Virol. 2018 Jul;28(4):e1979.
Pleural effusion and ascites can be detected
clinically depending on the level of plasma leakage
and volume. Chest X-ray examination (especially the
right lateral decubitus position) and abdominal
ultrasonography are useful adjuncts for diagnosis.
The degree of increase in the hematocrit level above
normal often indicates the severity of plasma leakage.
Persistent vomiting and severe abdominal pain
are early signs of plasma leakage, and may worsen or
persist when the patient is in shock. The patient
appears increasingly lethargic, but generally remains
conscious. Spontaneous mucosal bleeding or bleeding
at the site of blood collection is an important and
common bleeding manifestation. Hepatomegaly and
abdominal pain are also common. The findings of
signs and symptoms that are more severe than the
warning signs in (Table 3), indicate the condition and
classification of the patient as severe dengue.
A prospective multicenter clinical study in a
WHO/TDR-supported dengue endemic area pooled
evidence to establish criteria for classifying dengue
according to severity. The study findings confirm that
using a single set of clinical and/or laboratory parameters
can assess a clear difference between patients with severe
and non-severe dengue. However, for practical reasons,
the group of patients with non-severe dengue was divided
into two subgroups
namely dengue patients with warning signs and
without warning signs, for this reason the classification
of dengue diagnosis is as follows (Figure 4)11:
a) Dengue without warning signs.
b) Dengue with warning signs.
c) Severe dengue.
Figure 4. Classification of Dengue Infection
Source: WHO. Dengue guidelines for
diagnosis, treatment and control, 2009.
Dengue severity classification can be used practically
by doctors in determining management, how closely patients
need to be monitored during triage and hospitalization, for
more consistent reporting on a national and international
scale, and as a final step in vaccine trials and drug research.
Dengue patients without warning signs may develop severe
dengue. Comorbid factors in patients with dengue infection
allow the condition of dengue without warning signs to
progress to warning signs or severe dengue.
Severe dengue cases in Southeast Asia occupy
the highest place, namely 15% of all severe dengue
cases. Among the severe cases of dengue, 244 (90%)
had plasma leakage, 39 (14%) severe bleeding, and 28
(10%) severe organ dysfunction. The highest frequency
of plasma seepage occurs in the age group <15 years.
Severe dengue is defined as one or more of the
following conditions, (a) plasma leakage causing shock
(dengue shock) and/or accumulation of liquid
with/without respiratory distress, and/or(b) heavy
bleeding (c) severe organ damage
Increased vascular permeability is followed by severe
hypovolemia until shock occurs, occurring during
defervescence. Early in shock, compensatory
mechanisms occur to maintain a normal systolic
pressure, causing tachycardia and peripheral
pulse
narrowed
Parameter Circulation
Stable
Compensated
Shock
Decompensated
Shock
Pressure
pulsenormally fit
age
Postural
hypotension
Blood pressure is not
detected
Breathing
frequency
Frequency
breath
normalaccording to
age
Tachypnea Acidosis metabolic/
hyperpnea/Kussmaul
breathing
Diuresis Normal
For BB patient
<30 kgs
hence diuresis
ml/kgbb/hour m
For BB
patient
kg hence
diuresis
ml/kgbb/hour
There is a
decrease in
diuresis from
normal values
Anuria
Explanation of the normal values of
respiratory rate, heart rate and blood pressure in the
age group of infants and children:
Age Normal
breath rate
(upper limit)
Normal
heart rate
(upper limit)
Normal
systolic BP
(lower limit)
Normal MAP
(lower limit)
1 month 35 (55) 120 (175) 60 (50) 45 (35)
1 year 30 (40) 110 (170) 80 (70) 55 (40)
2 years 25 (30) 100 (160) 90+2*age#
(70+ 2* ages)#
55+ 1.5* age#
(40+1.5* ages)#
6 years 20 (25) 90 (130) 90+2*age#
(70+ 2* ages)#
55+ 1.5* age#
(40+1.5* ages)#
12 years
old
Source: European Pediatric Advanced Life Support. ERC Guidelines
2015 edition.
To recognize shock, when examining patients with
dengue infection, it is enough for health workers to simply
hold the patient's hand for 30 seconds to assess
hemodynamics in the form of adequacy of peripheral
perfusion and cardiac output, otherwise known as "the 5-in-
maneuver" magic touch (Figure 5). ).
Figure 5. The “5-in-1 maneuver” magic touch–CCTV-R
Source: Dengue clinical management: facilitator's
training manual. WHO 2013.
acute renal failure, encephalopathy or encephalitis,
cardiomyopathy or other unusual manifestations).
Further explanation regarding the definition of shock
and organ involvement in dengue infection is as follows: 12
a. Shock:
increased pulse rate (tachycardia), capillary refill
time of more than two seconds, cold extremities.
Pulse pressure narrows (<20 mm Hg).
Hypotension or until immeasurable.
The pulse feels weak and small until it can't be felt.
b. Hypotension:
A decrease in systolic blood pressure >40 mm Hg or
<2 SD below normal for the age group.
c. Respiratory distress (shortness of breath):
Respiratory rate increases with age.
Increased work of breathing (dyspnea).
Kussmaul breath.
Saturation 0 2 ≤94% without administration 02.
d. Cardiac involvement in the form of:
myocarditis.
Cardiomyopathy.
Heart failure.
e. Involvement of the central nervous system, in the form of:
metabolic disturbances or other explanations, or
finding the following signs:
neurological signs, and 3) seizures (not simple
febrile seizures).
Encephalopathy.
Encephalitis.
f. Renal involvement, in the form of:
value.
Assessment of AKI using the criteria of pediatric
RIFLE (RIFLE, an acronym for Risk of renal
dysfunction, Injury to the kidney, Failure of
kidney function, Loss of kidney function, and
End-stage Renal Disease
g. Liver involvement, in the form of:
jaundice,thromboplastin time <20%, and
encephalopathy.